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Abstract 
Extrahepatic bile duct cancer is an uncom-
mon disease, and few cases are curable by sur-
gery. We report a case of extrahepatic biliary
cystadenocarcinoma  (BCAC)  associated  with
atrophy of the left hepatic lobe. A 54-year old
male was admitted with painless obstructive
jaundice and a hepatic palpable mass noticed
one  month  before  presentation.  Liver  func-
tions  tests  were  consistent  with  cholestatic
damage and serum carbohydrate antigen 19.9
(CA  19-9)  was  increased  before  treatment.
Magnetic resonance imaging (MRI) disclosed
dilatation  of  the  left  hepatic  bile  duct  with
irregular wall thickening close to the hepatic
confluence, and atrophy of left hepatic lobe.
The patient was submitted to en bloc extended
left  hepatectomy  with  resection  of  caudate
lobe,  hilar  lymphadenectomy,  and  suprapan-
creatic biliary tree resection. All surgical mar-
gins were grossly negative, and postoperative
course was uneventful, except for a minor bile
leak. The patient was discharged on the 15th
postoperative day; he is alive without tumor
recurrence  one  year  after  primary  therapy.
Although technically challenging, extended en
bloc resection is feasible in adults with extra-
hepatic BCAC and can improve survival with
acceptable and manageable morbidity. 
Introduction 
Extrahepatic bile duct cancer is an uncom-
mon disease, and few cases are curable by sur-
gery. Prognosis depends in part on the tumor’s
anatomic location, which affects its resectabil-
ity with complete resection feasible in 25% to
30%  of  lesions  from  distal  bile  duct,  a
resectability rate clearly better than attained
in  lesions  at  more  proximal  sites.1-3 Adeno-
carcinoma comprises the most common histol-
ogy of bile duct cancer, and biliary cystadeno-
carcinoma (BCAC) is a quite rare entity.4
BCAC often occurs as slow growing lesion in
the liver parenchyma and is difficult to distin-
guish from its benign counterpart, biliary cys-
tadenoma.  In  addition,  BCAC  radiologically
resembles simple hepatic cysts, mainly when
unilocular,  hydatid  cysts,  and  a  number  of
metastatic tumors that undergo cystic degen-
eration. Extrahepatic BCAC have unique traits
with specialized treatment needs.2,5,6
We  describe  a  case  of  extrahepatic  BCAC
localized  closing  to  the  hepatic  duct  conflu-
ence. The patient successfully underwent suc-
cessfully  an  en  bloc  suprapancreatic  biliary
tract resection with left hepatectomy plus cau-
date lobectomy. 
Case Report 
An  otherwise  healthy  54-year-old  Cau  -
casian  male  was  admitted  to  the  surgical
ward  due  to  painless  obstructive  jaundice
and  a  hepatic  palpable  mass  which  was
noticed  one  month  before  presentation.
Serum  bilirubin  (241  µmol/L),  alkaline
phosphatase  (1067  U/L)  and  gamma  glu-
tamyl transferase (550 U/L) were markedly
elevated; serum aspartate aminotransferase
(175  U/L)  and  alanine  aminotransferase
(143 U/L) were only mildly elevated. Serum
levels  of  carcinoembryonic  antigen  and
alpha-fetoprotein were normal, but CA 19-9
was elevated (345 U/L). A CT scan showed a
cystic lesion with irregular wall thickening
near the hepatic hilum, dilatated intrahep-
atic bile ducts, and atrophy of the left hepat-
ic  lobe.  A  magnetic  resonance  cholan-
giogram  showed  dilatation  of  intrahepatic
biliary tree, predominantly at the left side,
absence of duct stones, and bile duct with
irregular wall thickening close to the hepat-
ic confluence (Figure 1). 
There were no suspicious findings of locore-
gional or systemic dissemination in imaging
studies.  Provisional  diagnoses  of  biliary
cyst  adenoma,  hilar  cholangiocarcinoma
(T3N0M0, stage IIIA) or extrahepatic bile duct
cancer (T3N0M0, stage IIA) were made, and
the  lesion  was  deemed  resectable.  Surgery
consisted of suprapancreatic biliary tree resec-
tion, including hepatic duct confluence, hilar
lymphadenectomy, and en bloc extended left
hepatectomy with caudate lobectomy. All surgi-
cal margins were negative. A histopathological
examination  showed  cystadenocarcinoma
arising from the left hepatic duct (Figure 2).
The  immunohistochemical  analysis  for  CEA,
cytokeratin  19  and  CA  19-9  showed  positive
staining  at  the  tumor  level.  Postoperative
course was uneventful, except for a minor bile
leak requiring no therapy. The patient was dis-
charged on the 15th postoperative day and no
postoperative adjuvant therapy was necessary.
He is alive without tumor recurrence one year
after the primary therapy. 
Discussion 
Biliary cystoadenocarcinoma is a rare, indo-
lent disease typically diagnosed in middle-aged
people.  It  predominantly  affects  women  and
has a less favorable outcome among men.4,7 At
diagnosis,  patients  with  intrahepatic  BCAC
often present for evaluation of an abdominal
mass or regional pain, but cholestasis is a fre-
quent and early feature in extrahepatic BCAC.8-11
Extrahepatic BCAC can cause asymmetric bile
duct  dilatation  and  secondary  segmental
hepatic  atrophy  due  to  adjacent  tumor  com-
pression  or  invasion  of  the  left  portal  vein,
pressure atrophy of hepatic cells, or bile salt
toxicity.12,13
Tumor  arises  more  frequently  from  the
hepatic confluence or sectoral bile ducts than
from  the  gallbladder.7,10,14 Endoscopic  retro-
grade  cholangiopancreatography  (ERCP)
ERCP  is  no  longer  a  decisive  component  in
diagnostic work-up as non-invasive modalities
clearly  elucidate  location  and  extent  of  dis-
ease. Imaging studies usually reveal multilocu-
lar cystic lesions with internal septations and
nodularities,  but  a  unilocular  lesion  may  be
observed  as  in  this  case.5,15,16 Some  authors
have  suggested  that  presence  of  nodules  or
coarse  calcifications  along  the  duct  wall  or
septa increases the odds in favor of BCAC.15,17
CA19-9 and CEA serum levels can be used in
conjunction  with  radiological  methods  to
determine tumor resectability: normal marker
levels  assure  resectability  in  half  of  cases,
while elevated CA 19-9 (>1000 U/mL) and CEA
(>14.4 ng/mL) strongly suggest unresectable
disease.18 The differential diagnosis includes
biliary  cystoadenoma,  cholangiocarcinoma
and, less commonly, benign papilloma, carci-
noid tumor, villous tumor, neurofibroma, and
plasmacytoma. Besides intraductal neoplasm,
the  differential  diagnosis  of  regional  biliary
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ductal  obstruction  includes  calculus  disease,
sclerosing  cholangitis,  metastatic  disease,
hepatoma, and hepatic cysts.4,9,19 In this case,
radiological findings of asymmetric bile duct
dilatation in the absence of identifiable calculi
and segmental hepatic atrophy favor a diagno-
sis of an intraductal neoplasm, such as hilar
cholangiocarcinoma or extrahepatic bile duct
cancer. 
Histology of BCAC is characterized by mod-
erate mitotic activity seen in papillary projec-
tions of stratified cells lining the foci of dyspla-
sia.7,10 Tumor  specimen  may  show  areas  of
frank stromal invasion, oncocytic differentia-
tion, have an endocrine cell component, and
coexist  with  benign  cystic  structures.20,21
Almost exclusively in females the underlying
layer of connective tissue shows a distinctive
aspect  with  increased  stromal  cellularity,
closely  resembling  ovarian  stroma.7,17 Rarely
the malignant epithelial cells exhibit a spindle-
shaped pseudosarcomatous morphology.22 Most
tumor cells are positive on immunohistochem-
ical  staining  for  tissue  polypeptide  antigen,
cytokeratin, CA 19-9, and CEA.7,10,23 Devaney et
al.7 noticed a favorable prognosis for tumors
with ovarian-like stroma, when compared to
those  predominantly  seen  in  males  having
notably  inconspicuous  stromal  features  and
increased propensity for locoregional dissemi-
nation.
Surgery is the mainstay of curative treat-
ment in localized extrahepatic bile duct can-
cer.1,24 The optimum surgical procedure (Table
1) will vary according to tumor location along
the  biliary  tree,  involvement  of  normal  liver
parenchyma, and the proximity of the tumor to
major blood vessels in this region (Table 1). En
bloc resection as performed may be necessary
to attain free surgical margins and favorable
outcome, as partial resection has been associ-
ated to high rates of recurrence and dismal
prognosis.1,2,6 Cytotoxic chemotherapy, target-
ed  therapy,  and  radiation  therapy  have  no
proven  role  in  the  management  of  BCAC
patients. 
Conclusions
Although technically challenging, extensive
hepatobiliary  resection  is  feasible  in  adults
with extrahepatic BCAC, and can offer long-
term survival with acceptable and manageable
morbidity.  Early  recognition  of  clinical  and
radiological features of rare tumors arising in
bile ducts enables the early diagnosis and suc-
cessful treatment. 
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Abstract 
Granulosa cell tumors can be classified into
juvenile and adult types and more commonly
occur in ovaries. Adult testicular granulosa cell
tumors are extremely rare and only 29 cases of
adult type have previously been reported.  We
report here a 28-year old Caucasian man with
a left testicular adult type granulosa cell tumor.
The  tumor  measured  2.6¥2.6¥2.5  cm  and
was mitotically active (10/10 HPF). Immuno-
histochemical  stains  showed  the  tumor  dif-
fusely positive for inhibin and vimentin, and
negative  for  epithelial  membrane  antigen,
cytokeratins, synaptophysin, HMB-45, OCT-4,
placental-like  alkaline  phosphatase  and  lym-
phoid  markers.  The  reported  granulosa  cell
tumors in adult testis were briefly reviewed. 
Introduction
Granulosa cell tumors can be classified into
juvenile and adult types. Juvenile type is usu-
ally benign. However, the clinical behavior of
adult type granulosa cell tumors is difficult to
predict. Testicular granulosa cell tumors are
extremely rare. Only 29 adult type granulosa
cell tumors in adult testicles have been report-
ed.  Analysis  of  the  previous  reported  cases
shows only tumor size of >5 cm reaches statis-
tical significance in association with adverse
clinical  behavior.1 We  report  a  new  case  of
adult type granulosa cell tumor in the testis
and briefly review the previously published lit-
erature.
Case Report
The patient is a 28-year-old Caucasian male
who presented for urological evaluation after
noting a firm lump in the left testicle. He com-
plained of mild left sided scrotal discomfort. He
denied  decreased  libido  or  erectile  dysfunc-
tion. Physical examination was normal except
for an enlarged hard left testicle. Of note, no
gynecomastia was noted. A trans-scrotal ultra-
sound confirmed a solid mass in left testicle.
Serum alpha-fetoprotein and human chorionic
gonadotropin levels were within normal limits.
Computed  tomography  (CT)  scans  of  chest,
abdomen,  pelvis  showed  no  evidence  of
metastatic  disease;  however,  an  enhancing
mass  in  left  hemiscrotum  was  identified
(Figure  1).  The  patient  underwent  a  left
inguinal orchiectomy. He recovered from his
procedure  uneventfully.  Macroscopically,  the
testicle and epididymis measured 5¥4¥4 cm.
The spermatic cord measured 5 cm in length
and 1 cm in diameter. There was a 2.6¥2.5¥2.5
cm well-circumscribed mass in the testicle. On
cut surface, the tumor was tan with a slight red
pallor. No hemorrhage or necrosis was seen.
Microscopically, the tumor was well circum-
scribed  with  focal  infiltration  of  testicular
parenchyma (Figure 2A,B). No involvement of
tunica  albuginea  was  seen.  The  tumor  was
composed  of  solid  sheets  of  cells  with  fine
chromatin and inconspicuous nucleoli. Focal
nuclear grooves were seen. The mitosis was
brisk  and  averaged  10/10  high  power  fields
(HPF). No atypical mitosis was seen. No necro-
sis or lymphovascular invasion was identified.
The rete testis, epididymis, and spermatic cord
were not involved. 
To further characterize the tumor, immuno-
histochemical stains were performed (Figure
2C/D).  The  tumor  was  strongly  positive  for
inhibin and vimentin, negative for epithelial
membrane  antigen  (EMA),  cytokeratins
(AE1/3,  cam5.2),  germ  cell  tumor  markers
(OCT-4, placental-like alkaline phosphatase),
melanocytic  markers  (S100,  HMB45),  lym-
phoma  markers  (LCA,  CD3,  CD5,  CD20,
CD79a, CD21, CD35).
The combined findings of morphology and
immunohistochemistry supported the diagno-
sis of primary testicular adult type granulosa
cell tumor.
Discussion
Granulosa cell tumor is a sex-cord stromal
tumor  which  more  commonly  occurs  in  the
ovary.
2 Granulosa cell tumor is extremely rare
in the adult testicle. Only 29 cases of testicular
adult type granulosa cell tumor have been pre-
viously reported.
3-11 A testicular granulosa cell
tumor usually presents as a painless mass in
the testicle. A small portion of patients may
present  with  gynecomastia.
12-15 The  average
age at presentation is 45 years (range 16-77
years). 
Granulosa cell tumor of the testicle, like its
ovarian  counterpart,  can  be  classified  into
juvenile or adult types. Juvenile type granulosa
cell tumor usually occurs in children, but very
rarely it can occur in an adult.
16 The tumor is
usually multicystic, and lacks the morphologi-
cal  features  of  the  adult  type  granulosa  cell
tumor  such  as  Call-Exner  bodies  or  coffee-
bean  nuclei.  Most  testicular  granulosa  cell
tumors  in  adults  are  adult  type.
1,7 Testicular
granulosa cell tumors usually do not invade the
tunica albuginea. Focal infiltration of the tes-
ticular parenchyma can be present.
1 No lym-
phovascular  invasion  is  usually  seen.  The
tumor can grow in multiple patterns, including
trabecular, insular, macrofollicular, mirofollic-
ular  and  gyriform  patterns.  The  nuclei  are
elongated,  sometimes  with  nuclear  grooves.
No  prominent  nucleoli  are  seen.  Mitosis  is
highly variable, ranging from 2 per 50 HPF to 3
per HPF6.
17 Call-Exner bodies may be present.
The  differential  diagnosis  for  a  testicular
granulosa  cell  tumor  includes  subtyping  the
tumors into adult or juvenile type; type 2 germ
cell tumors, especially yolk sac tumor; metasta-
tic  carcinoma;  carcinoid  tumors;  and,  non-
Hodgkin’s lymphoma. Adult type granulosa cell
tumors can be differentiated from the juvenile
type  by  the  presence  of  Call-Exner  bodies
and/or coffee-bean nuclei.  In contrast, juvenile
type is usually multicystic, and lacks the char-
acteristic features of adult type.
Immunohistochemically  granulosa  cell
tumor is positive for inhibin, vimentin and cal-
retinin, negative for epithelial membrane anti-
gen  (EMA),  placental  alkaline  phosphotase,
synaptophysin and lymphoid markers. Yolk sac
tumor  (YST)  of  mixed  malignant  germ  cell
tumors  can  show  multiple  growth  patterns.
However,  YST  is  usually  positive  for  PLAP,
cytokeratin and AFP, albeit it can also be posi-
tive for inhibin.
18Granulosa cell tumors need to
be differentiated from hematopoetic malignan-
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